アンジオテンシン変換酵素2は,心臓機能の重要なレギュレータです
Michael A Crackower1, Renu Sarao, Gavin Y Oudit
1Amgen Research Institute/Ontario Cancer Institute and Department of Medical Biophysics and Immunology, University of Toronto, University Avenue, Toronto, Ontario M5G 2M9, Canada.
Nature
|June 21, 2002
まとめ
アンジオテンシン変換酵素2 (ACE2) は,心臓の機能に不可欠です. ACE2の発現の減少は高血圧に関連しており,その障害は重度の心不全を引き起こし,心血管の健康におけるその役割を強調しています.
科学分野:
- 心血管生物学 心血管生物学
- 遺伝学 遺伝学とは
- 高血圧の研究研究
背景:
- 心血管疾患は死亡の主な原因である.
- 高血圧は,心血管疾患の主要な危険因子です.
- 心血管の健康におけるアニオテンシン変換酵素2 (ACE2) の役割については,さらなる解明が必要である.
研究 の 目的:
- 高血圧と心臓機能におけるアニオテンシン変換酵素2 (ACE2) の役割を調査する.
- 高血圧や心血管疾患に関連する遺伝因子を特定する.
主な方法:
- 高血圧のラットモデルにおけるX染色体上の定量的な特徴の場所 (QTL) にACE2遺伝子のマッピング.
- 高血圧ラットにおけるACE2メッセンジャーRNAとタンパク質発現の分析.
- ネズミにおけるACE2の遺伝子破壊の研究と,ドロソフィラの同型ACERの研究.
- ACE2変異マウスのACE遺伝子アブレーションを含む遺伝子救済実験.
主要な成果:
- ACE2は高血圧ラットのX染色体のQTLにマップされます.
- ACE2発現は高血圧ラット株で減少しています.
- マウスにおけるACE2の障害は,心臓の機能不全,アンジオテンシンIIの上昇,心臓の低酸素遺伝子の上昇を誘発する.
- ACE2の遺伝的消去は,ACE2変異マウスの心臓のフェノタイプを救出する.
- ドロソフィラのACERの破壊は,心臓の形質変異の欠陥を引き起こす.
結論:
- ACE2は高血圧関連QTLsの候補遺伝子である.
- ACE2は,心臓機能の重要なレギュラーである.
- ACE2によって調節されるレニン-アニオテンシン系は,心臓の健康を維持する上で重要な役割を果たします.
関連する概念動画
Hormonal Regulation
30.5K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
30.5K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.7K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.7K
Antihypertensive Drugs: Angiotensin II Receptor Blockers
3.0K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
3.0K
Antihypertensive Drugs: Direct Renin Inhibitors
1.9K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.9K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
2.1K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
2.1K
Heart Failure II: Pathophysiology
2.3K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.3K


